Review of current and emerging therapies in acute ischemic stroke
- 1Division of Neuroradiology, Department of Radiology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
- 2Division of Stroke, Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
- 3Division of Neurocritical Care, Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
- 4Division of Neurointervention, Department of Neurology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA
- Correspondence to
Roberta (Robin) Novakovic, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, Texas 75390-8896, USA; robin.novakovic{at}utsouthwestern.edu
- Received 16 April 2009
- Accepted 20 April 2009
Abstract
The statistics for stroke in the USA reads like a familiar ad slogan cited in most papers pertaining to acute ischemic stroke (AIS). Stroke is the third leading cause of death in the USA. While stroke ranks third among all causes of death, behind diseases of the heart and cancer, it is the leading cause of serious long-term disability in the USA.1 Approximately 795 000 people, 87% of whom are ischemic, suffer from stroke each year in the USA.2 That means that on average, every 40 seconds someone within the USA develops a stroke. For 2009 the combined direct and indirect cost of stroke, from hospitalization and rehabilitation to institutionalization, is estimated at $68.9 billion within the USA.2
Keywords:
Footnotes
-
Competing interests None.
